Drug Manufacturer Most Volatile: TherapeuticsMD Inc (NYSEMKT:TXMD), KaloBios Pharmaceuticals Inc (NASDAQ:KBIO), Aerie Pharmaceuticals Inc (NASDAQ:AERI), Auspex Pharmaceuticals, Inc. (NASDAQ:ASPX), Biostar Pharmaceuticals Inc (NASDAQ:BSPM)

Posted by on Jun 12, 2014

TherapeuticsMD Inc (NYSEMKT:TXMD), Director Cooper C. Collins bought 20,000 shares of TherapeuticsMD stock in a transaction dated Thursday, June 5th. The shares were purchased at an average price of $3.84 per share, for a total transaction of $76,800.00. Following the completion of the purchase, the director now directly owns 20,000 shares in the company, valued at approximately $76,800. TherapeuticsMD Inc (NYSEMKT:TXMD), weekly performance is 25.13%. On last trading day company shares ended up $4.78. Analysts mean target price for the company is $10.00. TherapeuticsMD Inc (NYSEMKT:TXMD), distance from 50-day simple moving average (SMA50) is 9.79%.

KaloBios Pharmaceuticals Inc (NASDAQ:KBIO), announced that the company will be presenting at the following investor conference: The 9th Annual JMP Securities Healthcare Conference Wednesday, June 25, 2014. KaloBios Pharmaceuticals Inc (NASDAQ:KBIO), advanced 4.69% in last trading session and ended the day on $2.23. KBIO, return on assets is -77.70%. KaloBios Pharmaceuticals Inc (NASDAQ:KBIO), quarterly performance is -30.75%.

Aerie Pharmaceuticals Inc (NASDAQ:AERI), announced that James Mazzo has been elected to the Company’s Board of Directors, effective June 11, 2014. Mr. Mazzo brings an impressive track record of leadership roles within the ophthalmic industry, including as the former head of Abbott Medical Optics, and currently serves as Operating Partner at Versant Ventures. Aerie Pharmaceuticals Inc (NASDAQ:AERI), shares moved up 2.09% in last trading session and was closed at $17.55, while trading in range of $16.80 – 18.22. Aerie Pharmaceuticals Inc (NASDAQ:AERI), year to date (YTD) performance is -2.28%.

Auspex Pharmaceuticals, Inc. (NASDAQ:ASPX), dropped 5.7% during mid-day trading on Wednesday after the company announced weaker than expected quarterly earnings, Analyst Ratings Network reports. The stock traded as low as $14.75 and last traded at $15.02, with a volume of 90,460 shares traded. The stock had previously closed at $15.92. Auspex Pharmaceuticals, Inc. (NASDAQ:ASPX), ended the last trading day at $20.82. Company weekly volatility is calculated as 7.80%. Auspex Pharmaceuticals, Inc. (NASDAQ:ASPX), showed a negative weekly performance of 2.07%.

Biostar Pharmaceuticals Inc (NASDAQ:BSPM), net profit margin is 2.00% and weekly performance is -0.71%. On last trading day company shares ended up $1.39. Analysts mean target price for the company is $7.00. Biostar Pharmaceuticals Inc (NASDAQ:BSPM), distance from 50-day simple moving average (SMA50) is -14.69%.

Leave a Reply

Your email address will not be published. Required fields are marked *